Ji-Yeon Han of Hanmi Science Receives Commendation from Commissioner of Intellectual Property
Recognized for Excellence in Establishing Intellectual Property Strategies and Securing Rights
Ji-Yeon Han, Executive Director and Head of the IP Team at Hanmi Science, has been selected by the Korean Patent Attorneys Association as a distinguished contributor in the field of IP competitiveness enhancement and received a commendation from the Commissioner of Intellectual Property.
Hanmi Group announced on July 22 that Executive Director Han received this award at the 80th anniversary celebration of the Korean Patent Attorneys Association held on June 26 at the association's headquarters in Seocho-dong, Seoul.
Hanmi Science's Jiyeon Han, head of the IP team (second from the right), is taking a commemorative photo with intellectual property contributors at the Korean Patent Attorneys Association's 80th anniversary ceremony held on June 26 at the Korean Patent Attorneys Association Hall in Seocho-dong, Seoul. Hanmi Science
View original imageTo mark its 80th anniversary, the Korean Patent Attorneys Association selected 43 distinguished contributors to intellectual property—including patent attorneys, corporations, research institutions, public organizations, and journalists—who have contributed to the advancement of patent, trademark, and design systems, technological innovation, and strengthening industrial competitiveness. The nominees received government awards and special merit plaques.
Hanmi Science explained that this honor reflects the external recognition of Hanmi Group’s R&D-driven management and intellectual property strategies.
Hanmi Group has continuously strengthened its intellectual property capabilities by linking patent strategies, rights acquisition, overseas applications, and license contract support from the early stages of new drug development, so that R&D achievements can become globally competitive assets. The company is also continuously building its portfolio and securing domestic and international rights for R&D assets, including biopharmaceuticals, combination and improved drugs, and platform technologies.
Executive Director Han is active not only in the domestic field of intellectual property but also on the international stage. From July 12 to 14, she participated as a Korean speaker at the “AIPPI Trilateral Meeting 2026” held in Guilin, China, where she gave a presentation on the theme “AI & IP: Bridging Innovation, Creation and Protection.”
AIPPI, established in 1897, is an international association of intellectual property professionals with about 9,000 members from 110 countries worldwide. This meeting, which alternates between Korea, China, and Japan, discussed topics such as AI and intellectual property, overseas application strategies, divisional applications and double patenting, and recent changes to intellectual property systems in each country. Executive Director Han introduced intellectual property issues and key practical considerations in patents related to the development of AI technology in Korea, and participated in discussions—the comparison of regulatory environments and industry responses by country.
Hanmi Science plans to further strengthen its intellectual property strategies, with the goal of protecting global R&D achievements and ensuring that technological innovation leads to business competitiveness. The company also intends to expand exchanges with international intellectual property networks to respond to the evolving technological landscape in fields such as AI, biotech, and platform technologies.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
Executive Director Han stated, “For research and development outcomes in new drugs to be fully recognized for their value in the global market, it is essential not only to innovate technologically but also to have intellectual property strategies that can protect and expand that innovation. We will continue to reinforce the IP foundation that underpins Hanmi’s R&D competitiveness, and proactively respond to changes in the global IP environment.”
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.